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The yeast two-hybrid method was used to screen mutagenized DNAs to isolate a variant of the human immunodeficiency
virus type 1 integrase (IN) that does not interact with the wild-type IN. The responsible mutation, leading to a single amino
acid change (V260E) in the C-terminal domain of IN, blocks IN–IN multimerization but has only small effect on binding to a
host interacting protein, INI1 (hSNF5). Binding studies in vitro confirmed the defect in multimerization of the mutant IN.
Biochemical analyses of the mutant IN enzyme expressed in bacteria detected only subtle changes in its properties,
suggesting that the yeast system is a sensitive reporter of correct IN conformation. Mutant virus carrying the V260E
substitution was blocked in replication at the time of DNA integration, consistent with IN multimerization being important for
its activity in vivo. © 1999 Academic Press
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tIntegration of a DNA copy of the viral genome into the
ost chromosome is an essential step in the life cycle of
etroviruses (for reviews see Andrake and Skalka, 1996;
sante-Appiah and Skalka, 1997; Goff, 1992; Vink and
lasterk, 1994). After retrovirus particles enter a host cell,
he RNA genome is reverse-transcribed to form a linear
ouble-stranded DNA that is subsequently integrated
nto the host genome to form the provirus. A single viral
nzyme, integrase (IN), mediates two major steps in the
rocess of integration (Katz et al., 1990). In the first step,
wo bases from the 39 ends of each DNA terminus are
emoved, leaving exposed 39 hydroxyl groups (39 pro-
essing); in the second step, the 39 ends of the viral DNA
re joined to 59 phosphate groups of the host DNA
strand transfer; Brown et al., 1989; Bushman and
raigie, 1991; Engelman et al., 1991). Most in vitro reac-
ions using recombinant IN are typically half-reactions
hat demonstrate correct cutting and processing of only
ne LTR end (Bushman et al., 1990; Craigie et al., 1990;
ujiwara and Craigie, 1989; Fujiwara and Mizuuchi, 1988;
atz et al., 1990; Katzman et al., 1989). In an infected cell
he two ends must be inserted into the target in a con-
erted reaction, and multiple lines of evidence suggest
hat integrase functions as an oligomer to act on both
NA ends. In solution, IN exists as a mixture of mono-
ers, dimers, and tetramers in equilibrium with the rel-
tive amounts dependent on the concentration (Jenkins
t al., 1996; van Gent et al., 1991). Direct examination of
ecombinant RSV integrase coupled with kinetic studies
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274ndicates that the active form is an oligomer (Jones et al.,
992); this oligomerization is stimulated by Zn21 (Lee et
l., 1997; Zheng et al., 1996) and Mn21 (Wolfe et al., 1996).
omplementation experiments with mixtures of defective
nd wild-type HIV-1 integrase also indicate that a multi-
eric form of the enzyme catalyzes the integrase reac-
ion in vitro (Engelman et al., 1993; van Gent et al., 1993),
nd protein cross-linking has further shown that IN ex-
sts as a multimer (Engelman et al., 1993; Heuer and
rown, 1997, 1998). Finally, tests of protein–protein inter-
ctions in the yeast two-hybrid system have directly
emonstrated that integrase can oligomerize (Kalpana
nd Goff, 1993).
Comparisons of the integrase sequences of various
etroviruses and retrotransposons as well as biochemi-
al studies indicate that integrase has three distinct
omains (Bushman et al., 1993; Engelman et al., 1993;
ngelman and Craigie, 1992; Khan et al., 1991; Leavitt et
l., 1993; Vincent et al., 1993; Vink et al., 1993): an N-
erminal zinc finger-like domain (typically contained in aa
–50), a central core domain with a conserved D,D35E
otif (aa 50–200), and a poorly conserved C-terminal
omain with nonspecific DNA binding activity. Probably
ll three domains of IN are involved in some aspect of
N–IN multimerization (Andrake and Skalka, 1995; Barsov
t al., 1996; Ellison et al., 1995; Jenkins et al., 1996). Direct
tructure analysis suggests that the N-terminal region is
dimer in solution (Cai et al., 1997). Biochemical comple-
entation studies suggest that the central core domain
s involved in multimerization (Engelman et al., 1993; van
ent et al., 1993). In addition, analyses of pools of de-
ected integrase clones in the yeast two-hybrid system
ndicate that the central core domain is essential for
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275AN OLIGOMERIZATION-NEGATIVE MUTANT OF HIV-1 INTEGRASEligomerization, though there are some requirements for
djacent domains (Kalpana and Goff, 1993). The results
f these biochemical and genetic studies are supported
y the X-ray crystal structure of the integrase core do-
ain (Dyda et al., 1994). In this crystal structure, the
entral core domain of integrase formed a dimer with
xtensive interactions throughout the length of the core
olypeptide. The C-terminal domain of the avian viral IN
as been demonstrated to self-associate by size-exclu-
ion chromatography, chemical cross-linking, and pro-
ein blot (Andrake and Skalka, 1995). NMR studies have
onfirmed that the C-terminal domain is a dimer in solu-
ion; the domain is composed of a five-stranded b-barrel
ith topology similar to that of the SH3 domain (Eijkelen-
oom et al., 1995; Lodi et al., 1995).
The overall oligomeric state of IN in vivo and the
pecific residues required for oligomeric contacts at the
N–IN interfaces remain uncertain. We have now used
he yeast two-hybrid system (Chien et al., 1991; Fields
nd Song, 1989) as a screening assay to identify specific
esidues involved in multimeric interactions of IN. In this
ystem, a library of IN mutants fused to the Gal4 DNA
inding domain (GAL4DB) is coexpressed with wild-type
N fused to the Gal4 activation domain (GAL4AC) in an
ndicator yeast strain. As reported previously, wild-type
N multimerizes in this system, resulting in the formation
f blue colonies in the X-gal assay (Kalpana and Goff,
993). Those rare IN mutants unable to interact with
ild-type IN result in white colonies in the X-gal assay.
sing this screening assay, we have identified a point
utation that causes an interaction-negative phenotype.
he mutant IN binds to wild-type IN poorly in vitro, ex-
ibits slightly decreased 39 processing and joining ac-
ivities, and exhibits disintegration activity comparable to
hat of wild-type IN in vitro, but does not support viral
ntegration in the context of the viral genome. The results
uggest that the multimeric interacting structures formed
n the yeast system are important for normal IN function
n vivo.
RESULTS
solation of interaction-negative mutants of IN
We have previously demonstrated that the multimer-
zation of HIV-1 IN can be monitored by using the yeast
wo-hybrid system: the coexpression of GAL4DB-IN
long with GAL4AC-IN in yeast results in the formation of
unctional activation complex that can be detected by the
ransactivation of a reporter lacZ gene (Kalpana and Goff,
993). To isolate interaction-negative mutants of IN, a
east plasmid encoding GAL4DB-IN (pMAI, Kalpana and
off, 1993) was subjected to mutagenesis by passage in
mutator strain of Escherichia coli (see Materials and
ethods). The pool of mutagenized DNA was then used
o transform the GGY1::171 yeast reporter strain along
ith an unmutagenized plasmid encoding wild-type tAL4AC-IN (pGADI; Fig. 1). Colonies were lifted to nitro-
ellulose and stained with X-gal. Of 2000 colonies
creened, 21 white colonies containing candidate mu-
ants were detected. To confirm the interaction-negative
henotype, plasmids were isolated from these 21 colo-
ies, recovered by cloning in E. coli, and retested by
ransformation of the GGY1::171 strain with GAL4AC-IN
NA. Fourteen of the clones resulted in Lac2 colonies,
hile the remaining 7 gave Lac1 colonies and were
iscarded. Restriction analysis of the 14 clones indicated
FIG. 1. Strategy for the isolation of interaction-negative mutants of IN.
AL4DB–IN expression plasmid (top) was mutagenized by passage
hrough a mutator E. coli. The library of mutant plasmids, along with
nmutagenized GAL4AC–IN, was introduced into the yeast reporter
train GGY1::171, and the resulting yeast transformants were stained
ith X-gal. Plasmid DNAs isolated from the white colonies (indicated by
he arrow) were retested and subjected to further analysis.hat 7 had undergone spontaneous deletion of the GAL4
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276 KALPANA ET AL.egion. DNA fragments containing the IN region from the
emaining 7 clones were isolated, recloned into the
AL4DB plasmid, and retested for their ability to trans-
ctivate lacZ when cotransformed with the GAL4AC-IN
lasmid. Four of the 7 clones resulted in blue colonies,
ndicating that the original mutations in these clones
esided elsewhere in the plasmid and not in the IN
egion. To determine whether the remaining 3 clones
ould direct the synthesis of full-length protein, the IN
ragment was cloned into a T7 expression vector, and
xpression of the mutant proteins was assessed by
estern analysis of lysates using IN antibodies. Only 1 of
he 3 clones (M5) expressed full-length IN protein, indi-
ating that mutations in the other 2 clones had caused
runcation of the protein or affected protein stability. The
utant M5 was characterized further.
etermining the change in the M5 mutant
The entire coding regions of both M5 and the wild-type
N were subjected to sequence analysis and compared.
single A-to-T transversion mutation was found near the
9 end of the mutant DNA; this mutation results in a
260E substitution. There was no other alteration in the
equence. To confirm that the V260E substitution was
esponsible for the interaction-negative phenotype, a
mall 39 fragment of M5 and the wild-type clone were
wapped, and the resulting chimeras were tested for
ligomerization in the two-hybrid system (Fig. 2). The
FIG. 2. Position of interaction-negative mutation in IN. The conserved
N; filled bar represents the mutant M5; the INM5 and M5IN bars repre
s shown at the bottom. The numbers indicate the IN residues. The chan
omain; D,D35E, the central domain with catalytic residues; C-tail, C-te
spartic acid; E, glutamic acid. The IN mutants were tested in the two-h
plus sign indicates blue colonies, and a minus sign indicates white-terminal fragment containing the mutation was able to gonfer the interaction-negative phenotype to the chi-
era, indicating that the substitution mutation was the
ause of the observed phenotype.
nteraction properties of the V260E mutant
The M5 mutant was originally isolated as a GAL4DB
usion protein that was unable to interact with IN fused
o GAL4AC. To test whether the interaction-negative
henotype was specific to the GAL4DB–IN fusion pro-
ein, and also to determine whether the mutant was
ble to homodimerize, the mutant IN protein was ex-
ressed as a GAL4AC fusion. All combinations of
utants and IN proteins fused to either GAL4DB or
AL4AC were coexpressed and tested for interaction
Fig. 3). The mutant M5 was unable to interact either
ith itself or with wild-type IN in any combination. In
ddition, we also tested to see whether the M5 mutant
nteracted with the integrase interactor 1 (INI1;
SNF5), a host protein first identified as binding to the
IV-1 IN (Kalpana et al., 1994). The M5 IN did indeed
nteract with INI1, although the activation of lacZ was
lightly weaker than seen with the wild-type IN–INI1
nteraction (Fig. 3). This result indicates that M5
akes a stable protein that is well folded, targeted to
he nucleus, and capable of interacting with some
roteins, but is specifically blocked in homomeric in-
eractions in the two-hybrid system. The results sug-
ns of IN are indicated at the top. The white bar indicates the wild-type
imeras containing IN and M5 fragments. A blow-up of the C-terminus
e sequence is indicated by an arrow and shaded letters. Zn, zinc finger
omain. Amino acid residues indicated are H, histidine; C, cysteine; D,
ystem as GAL4DB fusion proteins against GAL4AC–IN fusion protein.
s in the X-Gal assay.domai
sent ch
ge in th
rminal d
ybrid sest that M5 is a true interaction-negative mutant.
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277AN OLIGOMERIZATION-NEGATIVE MUTANT OF HIV-1 INTEGRASEffect of the V260E substitution on in vitro integration
ctivities
Recombinant IN protein is able to catalyze three spe-
ific reactions: 39 processing of the viral DNA termini,
oining of a processed terminus to a target DNA, and
isintegration, a reverse reaction in which a viral termi-
us is released from its target. To determine whether the
260E substitution affected 39 processing, joining, or
isintegration activities in vitro, the wild-type IN and M5
ere expressed with a hexa-histidine (6H) tag in bacteria
nd affinity-purified on Ni-NTA Sepharose columns. In
ddition, the two IN proteins were also expressed as
ST fusions and purified on glutathione beads. Process-
ng reactions were carried out under standard assay
onditions, with double-stranded labeled oligonucleo-
ides corresponding to the U5 end of HIV-1 DNA as
ubstrate, using similar amounts of 6H-IN and 6H-M5
Fig. 4a). To test for DNA joining activity, a labeled pre-
rocessed oligonucleotide corresponding to the U5 ter-
inus was used as a substrate and an unlabeled plas-
id DNA was used as target (Kalpana et al., 1994).
ntegration of the radiolabeled substrate into the target
as detected by autoradiography after gel electrophore-
is as labeled, tailed, circular molecules (Fig. 4b). Nor-
alized for the amount of protein added, the mutant
xhibited about threefold less processing and joining
ctivity compared to the wild-type, indicating that the
260E mutation modestly reduced the catalytic activity of
N. It has been demonstrated that IN can carry out
isintegration reactions even when multimerization is
revented and under conditions when the 39 processing
nd joining reactions are very inefficient (Barsov et al.,
996; Engelman and Craigie, 1992). To test for disinte-
ration activity, reactions were performed using a Y sub-
trate labeled at the 59 end (Chow et al., 1992); during the
eaction a 16-nt labeled oligonucleotide substrate is
oined to form a 30-nt radiolabeled product. The 6H–IN
FIG. 3. Interaction of M5 mutant with IN and Ini1 in the two-hybrid
ystem. DB, fusions to DNA binding domain; AC, fusion to activation
omain. The corresponding pairs of fusion proteins were tested for the
nteraction in the two-hybrid system and the results of the X-gal assay
re indicated. 11, dark blue, 1, light blue, and 2, white. IN, wild-type
N; M5, interaction-negative mutant; Ini1, fragment of Ini1 (aa 105–385)
hat binds to IN.nd GST–IN proteins both showed high levels of activity pFig. 4c). The GST-M5 also showed strong activity,
oughly in proportion to the amount of protein used in
hese assays. The results indicate that the V260E muta-
ion did not grossly affect the enzymatic activity, the
atalytic site, or the overall folding of the protein and
uggest that the primary defect is in multimerization.
n vitro interactions of IN and M5
To determine whether the defect in oligomerization in
he two-hybrid system could be detected in vitro, we
eveloped a simple binding assay using GST–IN immo-
ilized on beads and hexa-His tagged mutant and wild-
ype IN in solution. Glutathione beads were loaded with
ST, GST–IN, or GST–INI1 proteins and incubated with
acterial lysates containing 6H-M5 or 6H-IN proteins.
he beads were washed extensively and the bound
roteins were then eluted, separated by SDS gel elec-
rophoresis, and analyzed by immunoblotting with poly-
lonal anti-6H antibodies. The GST–IN beads bound the
ild-type 6H-IN efficiently (Fig. 5, lane 1), but bound the
H-M5 mutant protein only very poorly (lane 2). Although
he M5 lysates contained somewhat less protein than
he wild-type lysates (approximately 2-fold less), quanti-
ation showed that the beads bound 40-fold less of the
5 than the wild-type IN, suggesting a severe defect in
he interaction. As a control, the binding to a distinct
N-interacting protein, INI1 (hSNF5), was examined. The
ST–INI1 beads bound both the wild-type 6H-IN and the
H-M5 proteins efficiently, indicating that these proteins
ere capable of interacting; in fact, the beads bound the
5 mutant protein even more efficiently than the wild-
ype (Fig. 5, lanes 3 and 4). The GST beads showed no
onspecific binding of either protein. These results show
hat the M5 mutant integrase was specifically impaired in
ts interaction with the wild-type IN in this in vitro assay,
orrelating with its defect in the yeast system.
nalysis of effects of the M5 mutation on viral
eplication
IN is essential for productive infection by HIV-1
LaFemina et al., 1992; Sakai et al., 1993; Shin et al., 1994;
iskerchen and Muesing, 1995). To determine whether
he M5 mutant IN protein could function in vivo, the M5
utation was introduced into a molecular clone of the
IV-1 provirus. The ability of the mutant to assemble and
elease virions with properly processed Gag and Pol
roteins was assessed after transfection of COS7 cells
ith wild-type or mutant proviral DNA. Sixty hours post-
ransfection, culture supernatants were harvested, fil-
ered, and concentrated, and Western analysis of viral
roteins was carried out using equal volumes of concen-
rated virions. To detect the mature cleavage products of
r160gag-pol and Pr55gag, a polyclonal antiserum from HIV-
-infected patients was used, and to detect processed IN
rotein, a monoclonal anti-IN antiserum was used (Figs.
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278 KALPANA ET AL.A and 6B). The mature Gag and Pol cleavage products
ere detected in the medium after transfection with both
ild-type and M5 DNAs. The M5 mutant showed about a
hree- to fivefold reduction in the yield of all the proteins.
he relative proportions of each protein in the mutant
irus, however, were comparable to those of wild type
Fig. 6A). To determine whether the reverse-transcriptase
RT) activity of the mutant virus was affected, wild-type
nd mutant virions were isolated from equal volumes of
edium and assayed for RT activity (Goff et al., 1981).
he M5 mutant virus demonstrated about three to five
imes less RT activity than the wild type (data not shown),
onsistent with the reduced amounts of virion particles.
FIG. 4. Activities of V260E mutant in vitro. (a) 39 processing activity
n reaction buffer with 30 ng (lanes 2 and 4) or 90 ng (lanes 3 and
olyacrylamide gel electrophoresis followed by autoradiography. The p
ight. (b) DNA joining activity assayed using labeled oligonucleotide s
eaction products were detected by electrophoresis followed by autora
isintegration activity assayed using Y substrate and GST–IN (300 ng
ligonucleotide as substrate is converted to a 30-nt product. The positi
nd the major product at the right. The protein preparations were as ihis indicated that the RT activity per virion of the mutant das unaffected. Thus, the M5 viral proteins, including IN,
re produced, processed, and incorporated into virion
articles, with only a modest effect on the overall effi-
iency of the late stages of virus replication.
To determine whether the M5 mutation affected the
nfectivity of the virus, Jurkat cells were either infected
ith equal volumes of wild-type and mutant virion parti-
les harvested from transfected COS7 cells or trans-
ected with proviral DNA by the DEAE–dextran method
Reicin et al., 1995). In both infection and transfection,
nly integration-competent virus can spread in the cul-
ure. Viral propagation was monitored by assaying the RT
ctivity of the supernatant of the infected cells every 2–3
d using labeled oligonucleotide substrate. The 18-mer was incubated
ither 6H-M5 or 6H-IN proteins, and the products were analyzed by
of migration of products missing 2 nt at the 39 end is indicated at the
te and plasmid DNA as target and 90 ng each of 6H-IN and 6H-M5.
phy. The position of migration of circular product DNA is indicated. (c)
M5 (100 ng), and 6H-IN (90 ng) proteins per 30-ml reaction. A 16-mer
arker oligonucleotides is indicated at the left and that of the substrate
b.assaye
5) of e
osition
ubstra
diogra
), GST–ays (Fig. 7). RT activity of the wild type peaked 15 days
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279AN OLIGOMERIZATION-NEGATIVE MUTANT OF HIV-1 INTEGRASEostinfection, whereas that of the mutant showed only
ackground levels of activity throughout the time course
f the experiment. These results indicate that the mutant
irus is not capable of sustaining a spreading infection in
ulture.
FIG. 5. In vitro binding studies of mutant and wild-type IN proteins.
lutathione beads were loaded with GST–IN, GST–Ini1, or GST alone
s indicated and incubated with bacterial lysates containing hexa-
istidine-tagged mutant (6H-M5) or wild-type (6H-IN) integrase. The
eads were washed and the bound proteins were recovered and
nalyzed by electrophoresis and Western blot with anti-hexa-His anti-
odies (lanes 1–6). Aliquots of the lysates were analyzed directly to
onitor input protein (lanes 7 and 8). The position of migration of the IN
roteins is indicated. The levels of proteins were estimated by densi-
ometry.
FIG. 6. Western analysis of viral proteins in the wild-type and muta
ransfection with wild-type and mutant proviral DNA were separate
itrocellulose, and probed with HIV-1 antiserum (a) or monoclonal ant
ild-type HIV-1 virus; M5, R3B virus with V260E substitution in IN; mock, mocTo determine which stage of the viral life cycle was
ffected by the mutation, the ability of the M5 virus to
arry out DNA synthesis in vivo was assessed. Circular
orms of the retroviral genome containing one or two
TRs are produced only after the complete synthesis of
iral DNA and its transport to the nucleus (Brown et al.,
n particles. Virion-associated proteins released by COS7 cells after
lectrophoresis on an SDS–12% polyacrylamide gel, transferred to
tibody (b). Gag and Pol proteins are indicated by arrows. Lanes R3B,
FIG. 7. Infectivity of the mutant virus M5. Virion particles harvested
rom the supernatants of transfected COS7 cells were used to infect
urkat cells. Viral replication was monitored by measuring RT activity in
he culture supernatant at various times. Each RT value represents the
mount of activity in 1.5 ml of culture supernatant.nt virio
d by e
i-IN an
k-transfected cells.
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280 KALPANA ET AL.987). Thus the formation of the LTR–LTR junction of the
wo-LTR circle can be used as a marker of complete
DNA synthesis and nuclear entry of the virus preinte-
ration complex. Equal volumes of pelleted wild-type and
utant virions harvested from COS7 transfected cells
ere used to infect Jurkat cells. Twenty-four hours
ostinfection, the cells were lysed and total cellular DNA
as extracted. PCR analysis was performed on this DNA
ith primers specific for the LTR–LTR junction (Bukrinsky
t al., 1992). The PCR products were separated by elec-
rophoresis and detected by Southern analysis using a
adiolabeled third oligonucleotide as probe. DNA corre-
ponding to the two-LTR junction was detected in both
ild-type and mutant infected Jurkat cells (Fig. 8). Al-
hough the PCR–Southern assay is not strictly quantita-
ive, estimating the amount of circular DNA detected in
he mutant infected Jurkat cells suggested a reduction in
he yield that was roughly consistent with the reduced
irion particles present in the preparation. These results
ndicate that the mutant virus assembles and releases
irion particles, reverse-transcribes the RNA into DNA,
nd transports the preintegration complex to the nucleus
f the infected cell without gross defects. Thus, the
efect in the M5 mutant most likely occurs during the
FIG. 8. PCR analysis of unintegrated circular viral DNA. Cloned viral
NA was used to generate virus in COS7 cells, the virus was applied
o Jurkat cells, and the DNA isolated from these cells was subjected to
CR amplification. The product DNAs were displayed by electrophore-
is on an agarose gel and subjected to Southern analysis. The position
f the 595-bp LTR-LTR fragment hybridizing to the probe is indicated.
ock, mock-infected cells. HIV-gpt, an env-negative proviral DNA con-
rol. M5, mutant M5 proviral DNA. R3B, the wild-type proviral DNA.ormation of the provirus DNA itself. tDISCUSSION
A number of in vitro mutagenesis studies of IN have
elped to define residues essential for its various enzy-
atic activities (Cannon et al., 1994; Drelich et al., 1992;
ngelman and Craigie, 1992; Kulkosky et al., 1992; Leavitt
t al., 1993; Shin et al., 1994; Wiskerchen and Muesing,
995). We have used the yeast two-hybrid system to
creen specifically for integrase mutants that were de-
ective in homodimerization, identifying one mutation,
5, that resulted in an interaction-negative phenotype.
he M5 mutant IN did not interact either with itself or
ith wild-type IN in any combination in yeast. However,
he mutant protein was able to interact with INI1 (hSNF5),
he integrase interactor 1, indicating that the mutant was
till capable of heteromeric interactions. This test and
estern blot analysis indicated that the mutant was
xpressed stably in the yeast cells and was folded and
ocalized properly in the yeast nucleus to permit interac-
ion.
Our initial screen to isolate interaction-negative mu-
ants of IN resulted in only one true mutant. Modification
nd further improvement of this method should facilitate
arge-scale screening: in particular, early screening of
utants for the ability to produce stable protein by West-
rn blot should eliminate the isolation of mutants unable
o produce stable, full-length proteins. Counterscreens,
n which an interaction with a control protein is tested
nd selected for, can also be used to eliminate uninter-
sting mutants (Brachmann and Boeke, 1997; Vidal et al.,
996; White, 1996).
The general localization of the M5 mutation to the
-terminal domain is intriguing since this domain can be
eleted without loss of IN–IN dimerization in many as-
ays. Thus, one possibility is that M5 might actively
estabilize dimerization, in the sense that it might block
imerization more severely than the mere absence of the
-terminus. Alternatively, the M5 mutation may affect a
articular dimer interface needed specifically for the mul-
imerization of full-length IN into a larger structure. The
ctive form of the protein is probably tetrameric, and in
uch a structure there can be two distinct dimer inter-
aces. The C-terminal region may be involved in only one
f these contacts, and M5 may disrupt only this particular
nteraction. It is quite possible that the yeast system is
onitoring the formation of such a larger oligomer; the
AL4DB–IN protein is likely to form dimers on the DNA
nd to then interact with a dimeric GAL4AD–IN. The in
itro binding assay may also monitor such an interaction,
s the GST–IN protein on beads may exist as a dimer
hat presents the same surface to the soluble IN proteins
n the lysate. Interestingly, when the binding experiment
as reversed—with 6H-IN or 6H-M5 proteins bound to
i-NTA beads and GST–IN in solution—no difference
as observed between wild-type and mutant proteins inheir ability to bind to IN (data not shown). Thus, in some
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281AN OLIGOMERIZATION-NEGATIVE MUTANT OF HIV-1 INTEGRASEettings, the mutant protein may retain at least one
unctional interaction surface.
The M5 interaction-negative mutant recovered in this
creen proved to contain a valine to glutamic acid sub-
titution near the C-terminus of integrase. The simplest
xplanation is that the new residue might directly block
contact needed for oligomerization of IN. The structure
f a dimer of the C-terminal domain as determined by
MR (Eijkelenboon et al., 1995; Lodi et al., 1995) is
onsistent with this notion. The domain forms a five-
tranded b-barrel structure in solution, with residues in
trands 2, 3, and 4 forming the interface of the dimer. The
260 residue lies in b strand 4, and though not directly
onded to the other subunit, it is immediately adjacent to
residue (V259) directly in contact with a residue in the
ther subunit (I257). The side chain of the very next
esidue, K258, is critical for DNA binding and points
pward from a saddle-shaped groove in the dimer. The
ctivity and oligomerization properties of several mu-
ants of IN with substitutions of residues within the C-
erminal domain have recently been reported (Puras
utzke and Plasterk, 1998). Interestingly, the V260E mu-
ation did not affect the DNA binding activity of the
-terminal fragment of HIV-1 IN (aa 220–270), suggesting
hat this mutation does not grossly disrupt the folding of
he C-terminal domain (Puras Lutzke and Plasterk, 1998).
lthough preparations of the V260E mutant protein were
ot suitable for determining the oligomeric state, gel
iltration analysis indicated that mutant INs with substi-
ution of either of the nearby residues L241A or L242A
ere modestly impaired for tetramerization and not
imerization (Puras Lutzke and Plasterk, 1998). Thus,
hese results are consistent with the idea that the C-
erminal domain might be important for tetramerization,
ather than dimerization, of the full-length IN.
Assays of the activities of the M5 IN protein in vitro
ndicated that the mutation reduced the efficiency of 39
rocessing and joining about 3- to 5-fold, but had no
ffect on disintegration. It should be noted that the use of
N fusions in these assays could affect the total activities
nd could even mask some inherent defects in the native
rotein. Similar studies of the V260E mutant in another
aboratory recently showed a somewhat larger effect on
rocessing and joining—roughly a 10-fold reduction—
nd also showed no effect on disintegration in one assay
Puras Lutzke and Plasterk, 1998). The small quantitative
ifference in the effects seen by the two laboratories may
e due to differences in the methods of preparation of
he proteins or the assays. The results suggest to us that
he mutant protein can fold well enough to exhibit at least
inimal nonconcerted integration and disintegration re-
ctions in vitro. However, we cannot rule out the possi-
ility that the mutation may destabilize the native state of
he protein to some extent, and there may be some
efects beyond those that can be attributed solely to the
lock to oligomerization. pThe M5 mutation in the full-length genome of HIV-1
ad profound effects on HIV-1 replication. Western anal-
sis of the proteins in the virus particles indicates that
he mutation had only modest effects on the production,
rocessing, or incorporation of any of the viral proteins,
ncluding IN. PCR analysis of total DNA isolated from
urkat cells 24 h postinfection with mutant virus demon-
trated the presence of significant amounts of two-LTR
ircle junctions, indicating that the viral DNA was syn-
hesized and successfully entered the nucleus. This sug-
ests that the major defect was in viral integration in vivo
nd indicates that proper oligomerization of IN is essen-
ial for viral replication. This finding suggests that dis-
upting the oligomeric state of IN would be an effective
ntiviral strategy: drugs and dominant negative inhibitors
hat specifically affect the oligomerization of IN may be
seful therapeutically.
MATERIALS AND METHODS
east and bacterial strains
Standard cloning methods were carried out in strain
H5a. Mutagenesis of DNAs was performed in LE30 (a
utator strain with mutD5 mutation; Prasad et al., 1991);
lasmids were methylated by propagation in CC114 [del
ara,leu)7697, lacZ-amY14, galU, galK, hsdR2, hsdM1,
trAr, rifr, argE-am, srl::Tn10, recA1; Lobel and Goff, 1984].
L31 (DE3), carrying an integrated copy of the T7 poly-
erase gene, was used to express wild-type and mutant
ecombinant IN proteins. Two-hybrid tests were per-
ormed in Saccharomyces cerevisiae GGY1:171 (gal4
al80 ura3 his3 leu2; Gill and Ptashne, 1987).
onstruction of plasmid clones
Plasmids expressing GAL4IN fusion proteins, pMAI
GAL4DB fused to IN) and pGADI (GAL4AC fused to IN),
ave been previously described (Kalpana and Goff, 1993).
T7 expression vector, pT7fl1 (gift of Ron Swanstrom),
as modified to facilitate expression of mutant INs in E.
oli. The DNA was cleaved with NdeI, the single-
tranded overhangs were filled in using the Klenow frag-
ent of DNA PolI, and the blunt ends were ligated to
enerate plasmid p12K. DNA fragments containing IN
equences were excised from yeast plasmids by BamHI
leavage and transferred to p12K to generate expression
lones p12KM5 and p12KIN. To generate clones
QE32-IN and pQE32-M5 for the expression of Hexa-
istidine (6H) tagged IN proteins in bacteria, BamHI and
alI fragments encoding the wild-type and mutant IN
equences were isolated from the yeast plasmids and
igated to the bacterial expression vector pQE32 (Qia-
en), digested with the same restriction enzymes. To
enerate clones pGST-M5 and pGST-IN for the expres-
ion of GST fusion proteins, a BamHI fragment of IN and
BamHI to SalI fragment of M5 were cloned into plasmidGEX3X.
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282 KALPANA ET AL.The M5 mutation was transferred to a molecular clone
f the HIV-1 provirus in two steps. First, a BspMI frag-
ent (corresponding to bp 4317–5045 of the HxBC.2
irus) containing the M5 mutation was isolated from the
lasmid p12KM5 and was used to replace the corre-
ponding wild-type fragment in the plasmid pBSHIV.
lasmid pBSHIV is a Bluescript plasmid containing the
peI–SalI fragment (corresponding to bp 1506 to 5785) of
xBC.2. Second, the SpeI to SalI fragment containing the
5 mutation was used to replace the corresponding
egion of the HIV-1 proviral clone R73/BH10 (Aldovini and
einberg, 1990).
utagenesis of integrase
To generate a library of IN variants, plasmid pMAI was
irst introduced into CC114 to methylate the plasmid and
hen reisolated and used to transform the restriction
ositive (hsdR1) mutator strain LE30. To ensure that the
ost’s mutator phenotype was functioning, the rate of
utagenesis of a test plasmid in a number of indepen-
ent cultures of LE30 was determined as follows. LE30
acteria were streaked onto plates containing minimal
edium (M9) supplemented with casamino acids but
ithout thymidine; this medium limits the mutagenesis of
E30 genomic DNA. Competent cells were prepared
rom several individual colonies picked from the M9
lates and stored frozen. A test plasmid containing the
ull-length lacZ gene (pBW5; gift of LaDonne Schulman)
as introduced into aliquots from each batch of compe-
ent LE30 cells. Plasmid DNA was prepared from each
ool of transformants and introduced into a lacZam strain
f E. coli (CC114), and the percentage of mutant lacZ2
lasmids was estimated by scoring blue and white trans-
ormants on X-gal plates. LE30 mutator subclones typi-
ally induced 1–5% lacZ2 mutants. The batch of compe-
ent cells with the desired mutation rate was then trans-
ormed with the plasmid pMAI. Approximately 20 LE30
ransformants carrying the pMAI plasmid were inocu-
ated into LB and incubated overnight at 37°C to induce
utations. Plasmid DNA prepared from this culture
erved as the library of GAL4–IN mutants.
xpression and purification of IN proteins
GST–IN and GST–M5 proteins. Cultures of E. coli
train HB101 harboring either pGST–IN or pGST–M5
lasmids were used to produce the corresponding fu-
ion proteins. Bacterial cultures were induced by the
ddition of 1 mM IPTG. The washed cell pellet was
esuspended in lysis buffer (20 mM Tris–Cl, pH 8.0, 1 M
aCl, 1 mM EDTA, 1 mM PMSF) and lysed by passage
hrough a French press twice at approximately 1000 psi
ressure. The lysate was passed through an 18-gauge
eedle and clarified by centrifugation. The supernatant
as loaded onto a glutathione–agarose column equili-
rated with wash buffer [20 mM Tris–Cl, pH 8.0, 0.5 M caCl, 1 mM EDTA, 0.5% IGEPAL (a nonionic detergent;
igma), and 1 mM PMSF]. The column was washed
xtensively with wash buffer and the bound proteins
ere eluted with elution buffer (50 mM HEPES, pH 8.0, 20
M glutathione, 0.4 M NaCl, 0.1 M LiCl, 1 mM EDTA, 0.5%
GEPAL, and 1 mM PMSF). The eluted proteins were
ialyzed against several volumes of dialysis buffer (50
M HEPES, pH 8.0, 0.5 M NaCl, 0.1 mM EDTA, 20%
lycerol, 1% thiodiglycol, 1 mM PMSF) and stored at
70°C.
6H-IN and 6H-M5 proteins. Wild-type and mutant IN
roteins were isolated as described previously (Kalpana
t al., 1994) by FPLC on Ni-NTA Sepharose columns
Pharmacia). The level of expression of 6H-M5 protein
as two- to fivefold reduced compared to the level of
xpression of 6H-IN. The bound proteins were washed
nd then eluted using a gradient of 40–800 mM imida-
ole, and fractions containing IN and M5 were collected,
ooled, and dialyzed against buffer containing 20 mM
EPES, pH 7.2, 1 mM DTT, 1 mM EDTA, 0.5 M NaCl, 20%
lycerol, and 1 mM PMSF.
n vitro enzyme assays of GST fusion proteins
39 processing and DNA joining of 6H-IN and 6H-M5
usion proteins, and disintegration activities of GST-IN
nd GST-M5 fusion proteins, were assayed essentially
s described (Chow et al., 1992; Engelman et al., 1991)
sing radiolabeled substrates. Joining activity was stud-
ed using pBluescript plasmid as target DNA and prepro-
essed oligonucleotide substrates.
iral infectivity studies
COS7 cells were maintained in Dulbecco’s modified
agle’s medium supplemented with 10% fetal calf serum.
urkat cells were maintained in RPMI 60 medium with
0% fetal calf serum. Both wild-type and mutant viral
tocks were prepared by transfecting COS7 cells with 20
g of viral DNA per 2–4 3 106 cells by the calcium
hosphate precipitation method (Graham and van der
b, 1973). Sixty hours posttransfection, culture superna-
ants were harvested, filtered, and concentrated by cen-
rifugation through a 25% sucrose cushion in 10 mM
ris–HCl, 10 mM NaCl, and 1 mM EDTA (TNE) at 4°C for
h at 10,000 g (Reicin et al., 1995). Infectivity was tested
ither by infecting Jurkat cells with virions collected from
OS7 supernatants or by transfecting Jurkat cells with 1
g of R3B (wild type) or R3BM5 (mutant) proviral DNA by
he DEAE–dextran method (McCutchan and Pagano,
968). To test for the spread of virus throughout the cell
ulture, viral supernatants were harvested every 2 to 3
ays and assayed for RT activity (Goff et al., 1981).
estern analysis
Virion particles released from COS7 cells were con-
entrated as above and were lysed by the addition of
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283AN OLIGOMERIZATION-NEGATIVE MUTANT OF HIV-1 INTEGRASEriton X-100 as previously described (Reicin et al., 1995).
he viral protein samples were separated by electro-
horesis on an SDS–polyacrylamide gel, transferred to
itrocellulose, and probed with either HIV-1 infected pa-
ient antiserum 256 (kindly provided by John Moore) or
ouse anti-HIV-1 IN (gift of Dag Helland). Proteins were
isualized by the enhanced chemiluminescence method
s prescribed by the manufacturer (Amersham).
solation of DNA from infected cells and PCR analysis
Virions were harvested and pelleted from transfected
OS7 cell supernatants at 60 h posttransfection as de-
cribed above. The pelleted virions were resuspended in
00 ml of RPMI and placed at 4°C overnight. The virions
ere treated with 10 U of DNase A (Promega) for 20 min
t 37°C after the addition of MgCl2. Jurkat cells (6 3 10
6)
n 2.5 ml of RPMI containing 10% fetal calf serum and 0.8
g/ml of polybrene were added to the DNase A treated
irions. The cultures were incubated at 37°C for 2 h with
entle shaking every half-hour, diluted 10-fold with fresh
edium (lacking polybrene), and placed at 37°C.
wenty-four hours postinfection, the cells were har-
ested and total genomic DNA was prepared (Bukrinsky
t al., 1992). An aliquot of the total genomic DNA was
ubjected to PCR analysis using primers corresponding
o the U5 region of the plus strand (nucleotides 9650–
669) and the R region of the minus strand (nucleotides
591–9610). Nucleotide positions of the oligonucleotide
rimers are according to the sequence of Ratner et al.
1985). The PCR products were subjected to agarose gel
lectrophoresis and Southern analysis using a third oli-
onucleotide corresponding to nucleotides 9427–9446
s probe. This analysis detects a 595-bp DNA fragment
orresponding to the two-LTR junction of the circular viral
NA (Bukrinsky et al., 1992).
equence analysis
Primers ZG1 (59CCTGCCCTGTTTCTGC39), ZG2 (59GCCT-
ATCTCTTACCTG39), IN3 (59GGAGCTTTGCTGGTCC39),
nd IN4 (59CCCTGAAACATACATATGGTG39) were used to
equence the entire length of mutant and wild-type inte-
rases in clones p12KM5 and p12KIN, respectively. Se-
uences were determined by automated fluorescence se-
uencing methods. The presence of the mutation in clone
QE32-M5 was confirmed by sequencing the plasmids
sing the IN3 primer.
n vitro binding assays to monitor the association of
utant and wild-type HIV-1 IN
To determine the ability of the mutant IN protein to
ssociate with wild-type IN in vitro, a simple binding
ssay was used. GST fusion proteins were expressed
nd recovered on glutathione beads as described above.
he beads were washed and incubated with bacterialysates containing 6H-IN proteins as described previ- Cusly (Kalpana et al., 1994). After binding, the beads were
ashed three times, and the bound proteins were eluted
y boiling in sample buffer containing SDS and DTT and
ubjected to SDS—polyacrylamide gel electrophoresis.
he 6H-IN proteins were detected by immunoblotting
ith polyclonal anti-hexa-His antibodies by a chemilumi-
escence detection method (Pierce).
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